CMS Inc. features new and updated products, inks contract with Premier
Radiation treatment software and hardware provider CMS Inc. launched an array of new and updated products at this week's annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Atlanta.
The company unveiled CMS Broadband, a technology that allows clinicians to plan treatments - contour, place beams, change leaf positions, review and approve plans - remotely. XiO plans and Focal files can be accessed through any PC with high-speed internet access, CMS said.
CMS highlighted Certis, a new system that provides secure, long-term patient treatment data storage with centralized and protected critical information in patient, machine and system files. In addition, CMS said the technology provides authenticated and encrypted transactions that aid in HIPAA compliance. To facilitate the learning of the technology, CMS released an interactive, educational CD that explaining how physicists and clinicians utilize Certis appropriately to maximize results.
I-Beam is a mobile patient positioning system that uses ultrasound or other images to confirm the most accurate location of tumors or target regions. I-Beam features a position accuracy of +/-2-mm for each fraction, CMS said. New software features with I-Beam version 1.3 (available late fall 2004) include remote physician review, an electronic signature capability and customized reporting.
Version 4.2 of CMS's XiO treatment planning software now features a DVH-based optimization spreadsheet and interactive graphs for IMRT prescriptions. Users can add dose volume constraints to the optimization. Target volumes are defined using minimum and maximum doses, while critical organs are defined using a combination of a maximum and up to five dose volume points, CMS said.
CMS also released Focal 4.2 CT software. The software now features 3D contouring so clinicians can contour a treatment image from any plane and with greater image clarity. The software is DICOM compatible and works with any other planning system, in multiple hospital environments.
Version 3.2 of CMS's Interplant software offers fusion of post-plan seed locations with intra-operative, or preplan, seed locations for dose comparison. The new release accepts seed location data from IPAS Version 3.0, improving the clinician's ability to compare post-treatment plans with pre-plans or intra-operative plans, CMS said.
Finally, CMS announced at ASTRO a contract it was awarded by Premier Purchasing Partners LP. The agreement with Premier offers Premier members access to CMS radiation treatment planning products. As part of the agreement, CMS said Premier partners may receive special pricing for CMS products and services.
The company unveiled CMS Broadband, a technology that allows clinicians to plan treatments - contour, place beams, change leaf positions, review and approve plans - remotely. XiO plans and Focal files can be accessed through any PC with high-speed internet access, CMS said.
CMS highlighted Certis, a new system that provides secure, long-term patient treatment data storage with centralized and protected critical information in patient, machine and system files. In addition, CMS said the technology provides authenticated and encrypted transactions that aid in HIPAA compliance. To facilitate the learning of the technology, CMS released an interactive, educational CD that explaining how physicists and clinicians utilize Certis appropriately to maximize results.
I-Beam is a mobile patient positioning system that uses ultrasound or other images to confirm the most accurate location of tumors or target regions. I-Beam features a position accuracy of +/-2-mm for each fraction, CMS said. New software features with I-Beam version 1.3 (available late fall 2004) include remote physician review, an electronic signature capability and customized reporting.
Version 4.2 of CMS's XiO treatment planning software now features a DVH-based optimization spreadsheet and interactive graphs for IMRT prescriptions. Users can add dose volume constraints to the optimization. Target volumes are defined using minimum and maximum doses, while critical organs are defined using a combination of a maximum and up to five dose volume points, CMS said.
CMS also released Focal 4.2 CT software. The software now features 3D contouring so clinicians can contour a treatment image from any plane and with greater image clarity. The software is DICOM compatible and works with any other planning system, in multiple hospital environments.
Version 3.2 of CMS's Interplant software offers fusion of post-plan seed locations with intra-operative, or preplan, seed locations for dose comparison. The new release accepts seed location data from IPAS Version 3.0, improving the clinician's ability to compare post-treatment plans with pre-plans or intra-operative plans, CMS said.
Finally, CMS announced at ASTRO a contract it was awarded by Premier Purchasing Partners LP. The agreement with Premier offers Premier members access to CMS radiation treatment planning products. As part of the agreement, CMS said Premier partners may receive special pricing for CMS products and services.